Certara (NASDAQ:CERT) Hits New 12-Month Low – Here’s What Happened

Shares of Certara, Inc. (NASDAQ:CERT) hit a new 52-week low during trading on Friday . The stock traded as low as $9.25 and last traded at $9.44, with a volume of 105418 shares. The stock had previously closed at $9.78.

Wall Street Analyst Weigh In

Several research firms recently weighed in on CERT. William Blair reiterated a “market perform” rating on shares of Certara in a report on Thursday, February 27th. Barclays boosted their price objective on Certara from $12.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, February 28th. TD Cowen assumed coverage on Certara in a report on Thursday, February 27th. They set a “buy” rating and a $16.00 target price for the company. Finally, Stephens reiterated an “overweight” rating and set a $17.00 price target on shares of Certara in a research note on Thursday, February 27th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $15.83.

Certara Trading Down 2.4 %

The company has a current ratio of 2.86, a quick ratio of 2.86 and a debt-to-equity ratio of 0.28. The company has a market cap of $1.54 billion, a PE ratio of -47.75, a P/E/G ratio of 9.29 and a beta of 1.64. The company has a fifty day simple moving average of $12.14 and a two-hundred day simple moving average of $11.41.

Institutional Trading of Certara

Large investors have recently made changes to their positions in the company. Versant Capital Management Inc lifted its stake in Certara by 218.8% in the first quarter. Versant Capital Management Inc now owns 2,719 shares of the company’s stock worth $27,000 after acquiring an additional 1,866 shares during the last quarter. Venturi Wealth Management LLC raised its holdings in shares of Certara by 839.1% in the 4th quarter. Venturi Wealth Management LLC now owns 2,808 shares of the company’s stock valued at $30,000 after purchasing an additional 2,509 shares in the last quarter. Wells Fargo & Company MN lifted its position in shares of Certara by 48.4% during the 4th quarter. Wells Fargo & Company MN now owns 3,208 shares of the company’s stock worth $34,000 after purchasing an additional 1,047 shares during the last quarter. Johnson Financial Group Inc. acquired a new position in shares of Certara during the fourth quarter worth $47,000. Finally, Blue Trust Inc. increased its holdings in Certara by 20.9% in the fourth quarter. Blue Trust Inc. now owns 4,747 shares of the company’s stock valued at $56,000 after buying an additional 822 shares during the last quarter. 73.96% of the stock is currently owned by hedge funds and other institutional investors.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.